TYK152: Difference between revisions
m 1 revision imported |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| Line 40: | Line 40: | ||
<p style="text-align: center;">[[TYK151|<Prev Question]] --- [[TYK153|Next Question>]]</p> | <p style="text-align: center;">[[TYK151|<Prev Question]] --- [[TYK153|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
Latest revision as of 02:18, 25 September 2026
ε-Aminocaproic acid (EACA) and tranexamic acid reduce surgical bleeding due to:
a) Prevention of fibrin degradation
b) Enhanced platelet function
c) Replacement of depleted coagulation factors
d) Antagonism of antithrombin activity
e) Stimulation of tissue factor production
Click for Answer
Answer
Answer a.
ε-Aminocaproic acid (EACA) and tranexamic acid are lysine analogues that bind to plasminogen and plasmin, interfering with the interaction of plasmin with fibrin and preventing fibrin degradation.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.
Keywords